Boykо, A.,
Fernández, O.,
Alifirova, V.,
Babicheva, N.,
Bakhtiyarova, K.,
Volkov, A.,
Glavinskaya, N.,
Goncharova, Z.,
Greshnova, I.,
Smagina, I.,
Lashch, N.,
Inzhinova, A. (2021) to start with the second
line of disease-modifying therapy (DMT), a lower percentage would choose dimethyl
Smirnova, L. A.,
Spasov, A. A.,
Khaliullin, F. A.,
Kucheryavenko, A. F.,
Ryabukha, A. F.,
Abramov, O. K. (2021) antiplatelet drug 3-methyl-8-(piperazin-
1-yl)-7-(thietan-3-yl)-
1-ethyl-
1H-purine-2,6(3H,7H)-dione hydrochloride
Роль мутаций в гене NF1 в спорадическом канцерогенезеThe review article presents data on somatic inactivation of NF
1 gene as a cause of sporadic